Clinical Trial

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

Study acronym: STABLE-MATES
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To Determine if SAbR improves survival over SR in High Risk Operable Stage I NSCLC
Protocol Amendment History 41 amendments
This ClinicalTrials.gov record has been amended 41 times since 2015-06-05; most recent amendment 2026-04-14.
Status change: Active, Not Recruiting → Recruiting 2020-06-11
Status change: Recruiting → Active, Not Recruiting 2020-05-12
Status change: Not Yet Recruiting → Recruiting 2015-09-12
Trial Details
NCT Number NCT02468024
Lead Sponsor University of Texas Southwestern Medical Center
Conditions Non-Small Cell Lung Cancer
Enrollment 272 participants
Start Date 2015-07
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-16